Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Deloitte
Boehringer Ingelheim
Argus Health
Colorcon
Medtronic
Novartis
AstraZeneca
Queensland Health
Moodys

Generated: October 18, 2017

DrugPatentWatch Database Preview

TEMAZEPAM Drug Profile

« Back to Dashboard

What is the patent landscape for Temazepam, and what generic Temazepam alternatives are available?

Temazepam is a drug marketed by Duramed Pharms Barr, Actavis Elizabeth, Mylan, Sandoz, Watson Labs, Novel Labs Inc, Sun Pharm Inds, Prinston Inc, Amneal Pharms, and Usl Pharma. and is included in nineteen NDAs.

The generic ingredient in TEMAZEPAM is temazepam. There are seven drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the temazepam profile page.

Summary for Tradename: TEMAZEPAM

US Patents:0
Applicants:10
NDAs:19
Suppliers / Packagers: see list39
Bulk Api Vendors: see list15
Clinical Trials: see list6
Patent Applications: see list3,615
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TEMAZEPAM at DailyMed

Pharmacology for Tradename: TEMAZEPAM

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Usl Pharma
TEMAZEPAM
temazepam
CAPSULE;ORAL070490-001Jul 7, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
TEMAZEPAM
temazepam
CAPSULE;ORAL203482-004May 23, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TEMAZEPAM
temazepam
CAPSULE;ORAL070383-001Mar 23, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Duramed Pharms Barr
TEMAZEPAM
temazepam
CAPSULE;ORAL071708-001Sep 29, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
TEMAZEPAM
temazepam
CAPSULE;ORAL071175-002Sep 14, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
TEMAZEPAM
temazepam
CAPSULE;ORAL078581-001Sep 8, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
TEMAZEPAM
temazepam
CAPSULE;ORAL070920-003Jun 12, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
TEMAZEPAM
temazepam
CAPSULE;ORAL071620-001Aug 7, 1987ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TEMAZEPAM
temazepam
CAPSULE;ORAL071447-001May 21, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Prinston Inc
TEMAZEPAM
temazepam
CAPSULE;ORAL201781-001Jun 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Healthtrust
McKinsey
Accenture
Cerilliant
Cantor Fitzgerald
Teva
Citi
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot